Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp gained 0.500% compared to yesterday.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | 0.500% | 5.789% | -1.471% | -28.214% | -26.909% | 204.545% | -43.380% |
| Intellia Therapeutics Inc | -6.160% | 1.692% | 3.265% | 99.073% | 53.984% | -65.370% | -79.572% |
| Cardio3 Biosciences S.A. | -2.140% | -23.077% | 0.719% | -34.426% | 107.407% | -58.457% | -95.214% |
| Polynovo Ltd | 0.890% | 4.630% | 0.000% | 1.802% | -16.912% | -46.698% | -71.320% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat